Name: PACIFIC BIOSCIENCES OF CALIF (PACB) Stock
Brand: PACIFIC BIOSCIENCES OF CALIF
Rating: 6 (3 reviews)

PACB Latest News, Press Relases and Analysis

All

Press Releases

10 days ago - By: PacBio

PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference

12 days ago - By: Zacks Investment Research - Mentions: AORT

Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?

a month ago - By: Benzinga - Mentions: TECH INSE GEF SKYT ...

Earnings Scheduled For November 5, 2025

20 days ago - By: Zacks Investment Research - Mentions: ILMN EDIT NTLA CRSP ...

Top 3 Genomics Stocks to Consider for Your Portfolio

25 days ago - By: Zacks Investment Research

Pacific Biosciences (PACB) Upgraded to Buy: Here's Why

a month ago - By: Zacks Investment Research - Mentions: BSX WST EXAS

PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y

a month ago - By: Benzinga - Mentions: PBM ARAY ACHC WORX ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session

a month ago - By: Zacks Investment Research

Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics

a month ago - By: Zacks Investment Research - Mentions: CLPT

Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates

a month ago - By: PacBio

PacBio Announces Third Quarter 2025 Financial Results

a month ago - By: PacBio

HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes

a month ago - By: Zacks Investment Research

Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

a month ago - By: PacBio

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

2 months ago - By: PacBio

PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025

2 months ago - By: Zacks Investment Research - Mentions: ILMN QGEN TXG

PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations

2 months ago - By: PacBio

PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities

2 months ago - By: PacBio

PACIFIC BIOSCIENCES OF CALIF (PACB) Stock News

PACB Latest News, Press Relases and Analysis

PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference

Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?

Earnings Scheduled For November 5, 2025

Top 3 Genomics Stocks to Consider for Your Portfolio

Pacific Biosciences (PACB) Upgraded to Buy: Here's Why

PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics

Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates

PacBio Announces Third Quarter 2025 Financial Results

HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes

Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025

PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations

PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities

PacBio HiFi Technology Selected as Core Platform for South Korea’s National Pangenome Project